Compassionate Use Questions Could Arise At FDA/Patient Meeting On IPF Treatments
This article was originally published in The Pink Sheet Daily
Executive Summary
InterMune already has made its pirfenidone available to idiopathic pulmonary fibrosis patients on a compassionate-use basis.